https://www.selleckchem.com/pr....oducts/bms-986165.ht
for higher-risk patients, as well as more aggressive antibiotic therapy at bacteremia onset. Our results indicate that P. aeruginosa and S. aureus bacteremia are associated with a greater incidence of intracranial hemorrhage and worse neurological outcomes. Future management considerations may include pre-implantation cerebrovascular imaging to assess vascular pathology including prior aneurysms and intracranial atherosclerotic disease burden as a screen for higher-risk patients, as well as more aggressive antibiotic therapy at bacte
Like
Comment
Share
